Advertisement

Legal, Ethical, and Professional Issues Related to Use of Psychotropic Medications in School-Aged Populations

  • George J. DuPaulEmail author
  • Melanie K. Franklin
Chapter
Part of the Pediatric School Psychology book series (PSP)

Abstract

Given the important involvement of psychologists and school professionals in psychopharmacological treatment, the purpose of this chapter is to address legal, ethical, and professional issues related to the use of psychoactive medications in the school-aged population. Specific attention is given to the implications of these issues for the roles and responsibilities of school personnel when working with families and physicians around medication treatment decisions. The chapter concludes with a list of readings and websites that may be helpful for readers seeking more information on this topic.

Keywords

Legal Ethical Psychopharmacology Psychotropic medication Roles School psychology 

References

  1. Arnold, L. E., Hodgkins, P., Caci, H., Kahle, J., & Young, S. (2015). Effect of treatment modality on long-term outcomes in attention-deficit/hyperactivity disorder: A systematic review. PLoS ONE, 10(2), e0116407.CrossRefGoogle Scholar
  2. Ball, C. R., Kratochwill, T. R., Johnston, H. F., & Fruehling, J. J. (2009). Limited prescription privileges for psychologists: Review and implications for the practice of psychology in the schools. Psychology in the Schools, 46, 836–845.CrossRefGoogle Scholar
  3. Baweja, R., Belin, P. J., Humphrey, H. H., Babocsai, L., Pariseau, M. E., Waschbusch, D. A., … Waxmonsky, J. G. (2016). The effectiveness and tolerability of central nervous system stimulants in school-age children with attention-deficit/hyperactivity disorder and disruptive mood dysregulation disorder across home and school. Journal of Child and Adolescent Psychopharmacology, 26, 154–163.CrossRefGoogle Scholar
  4. Bramness, J. G., Engeland, A., & Furu, K. (2007). Use of antidepressants among children and adolescents–did the warnings lead to fewer prescriptions? Tidsskrift for den Norske Laegeforening, 127(20), 2653–2655.PubMedGoogle Scholar
  5. Brown, R. T., Antonuccio, D., DuPaul, G. J., Fristad, M., King, C. A., Leslie, L. K., … Vitiello, B. (2008). Childhood mental health disorders: Evidence base and contextual factors for psychosocial, psychopharmacological, and combined interventions. Washington, DC: American Psychological Association.Google Scholar
  6. Carlson, J. S., Demaray, M. K., & Hunter-Oehmke, S. (2006). A survey of school psychologists’ knowledge and training in child psychopharmacology. Psychology in the Schools, 43, 623–633.CrossRefGoogle Scholar
  7. DuPaul, G. J., & Carlson, J. S. (2005). Child psychopharmacology: How school psychologists can contribute to effective outcomes. School Psychology Quarterly, 20, 206–221.CrossRefGoogle Scholar
  8. Fabiano, G. A., Pelham, W. E. Jr., Gnagy, E. M., Burrows-MacLean, L., Coles, E. K., Chacko, A., … Robb, J. A. (2007). The single and combined effects of multiple intensities of behavior modification and methylphenidate for children with attention deficit hyperactivity disorder in a classroom setting. School Psychology Review, 36, 195–216.Google Scholar
  9. Gureasko-Moore, D., DuPaul, G. J., & Power, T. J. (2005). Stimulant treatment for ADHD: Medication monitoring practices of school psychologists. School Psychology Review, 34, 232–245.Google Scholar
  10. Gutheil, T.G. (2012). Reflections on ethical issues in psychopharmacology: An American perspective. International Journal of Law and Psychiatry, 35, 387–391.CrossRefGoogle Scholar
  11. Haynes, R. B. (1979). Introduction. In R. B. Haynes, D. W. Taylor, & D. C. Sackett (Eds.), Compliance in health care (pp. 1–7). Baltimore: The Johns Hopkins University Press.Google Scholar
  12. Hilt, R. J., Chaudhari, M., Bell, J. F., Wolf, C., Koprowicz, K., & King, B. H. (2014). Side effects from use of one or more psychiatric medications in a population-based sample of children and adolescents. Journal of Child and Adolescent Psychopharmacology, 24, 83–89.CrossRefGoogle Scholar
  13. Howie, L. D., Pastor, P. N., & Lukacs, S. (2014). Use of medication prescribed for emotional or behavioral difficulties among children aged 6–17 years in the United States, 2011–2012. NCHS Data Brief, 148, 1–8.Google Scholar
  14. Individuals with Disabilities Education Act, 20 U.S.C. § 1400 (2004).Google Scholar
  15. Jacob, S., & Hartshorne, T. S. (2007). Ethics and law for school psychologists (5th ed.). Hoboken: Wiley.Google Scholar
  16. Koelch, M., Schnoor, K., & Fegert, J. M. (2008). Ethical issues in psychopharmacology of children and adolescents. Current Opinion in Psychiatry, 21, 598–605.  https://doi.org/10.1097/YCO.0b013e328314b776.CrossRefPubMedGoogle Scholar
  17. Lloyd, B. P., Torelli, J. N., & Symons, F. J. (2016). Issues in integrating psychotropic and intensive behavioral interventions for students with emotional and behavioral challenges in schools. Journal of Emotional and Behavioral Disorders, 24, 148–158.CrossRefGoogle Scholar
  18. Mazur-Mosiewicz, A., Pierson, E. E., & McIntosh, D. E. (2009). Legal issues in school health services and school psychology: Guidelines for the administration of medication. Psychology in the Schools, 46, 813–819.CrossRefGoogle Scholar
  19. Nyarko, K. A., Grosse, S. D., Danielson, M. L., Holbrook, J. R., Visser, S. N., & Shapira, S. K. (2017). Treated prevalence of attention-deficit/hyperactivity disorder increased from 2009 to 2015 among school-aged children and adolescents in the United States. Journal of Child and Adolescent Psychopharmacology.  https://doi.org/10.1089/cap.2016.0196. Advance online publication.CrossRefGoogle Scholar
  20. Olfson, M., He, J., & Merikangas, K. R. (2013). Psychotropic medication treatment of adolescents: Results from the National Comorbidity Survey-Adolescent Supplement. Journal of the American Academy of Child and Adolescent Psychiatry, 52, 378–388.CrossRefGoogle Scholar
  21. Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353, 487–497.CrossRefGoogle Scholar
  22. Page, T. F., Pelham, W. E. III, Fabiano, G. A., Greiner, A. R., Gnagy, E. M., Hart, K. C., … Pelham, W. E. Jr. (2016). Comparative cost analysis of sequential, adaptive, behavioral, pharmacological, and combined treatments for ADHD. Journal of Clinical Child and Adolescent Psychology, 45, 416–427.  https://doi.org/10.1080/15374416.2015.1055859.CrossRefGoogle Scholar
  23. Pelham, W. E. Jr., Fabiano, G. A., Waxmonsky, J. G., Greiner, A. R., Gnagy, E. M., Pelham, W. E. III., … Murphy, S.A. (2016). Treatment sequencing for childhood ADHD: A multiple-randomization study of adaptive medication and behavioral interventions. Journal of Clinical Child and Adolescent Psychology, 45, 396–415.  https://doi.org/10.1080/15374416.2015.1105138.CrossRefGoogle Scholar
  24. Peterson, A. M., Takiya, L., & Finley, R. (2003). Meta-analysis of trials of intervention to promote medication adherence. American Journal of Health-System Pharmacy, 60, 657–665.CrossRefGoogle Scholar
  25. Power, T. J., & Bradley-Klug, K. L. (2012). Pediatric school psychology: Conceptualization, applications, and strategies for leadership development. New York: Routledge.CrossRefGoogle Scholar
  26. Power, T. J., DuPaul, G. J., Shapiro, E. S., & Kazak, A. E. (2003). Promoting children’s health: Integrating health, school, family, and community systems. New York: Guilford.Google Scholar
  27. Rapoff, M. A. (2010). Adherence to pediatric medical regimens (2nd ed.). New York: Springer.CrossRefGoogle Scholar
  28. Rappaport, N., Kulick, D., & Phelps, L. (2013). Psychotropic medications: An update for school psychologists. Psychology in the Schools, 50, 589–600.CrossRefGoogle Scholar
  29. Roberts, H. J., Floress, M. T., & Ellis, C. R. (2009). Training school psychologists in psychopharmacology consultation. Psychology in the Schools, 46, 827–835.CrossRefGoogle Scholar
  30. Ryan, J. B., Katsiyannis, A., Losinski, M., Reid, R., & Ellis, C. (2014). Review of state medication policies/guidelines regarding psychotropic medications in public schools. Journal of Child and Family Studies, 23, 704–715.CrossRefGoogle Scholar
  31. Ryan, J. B., Katsiyannis, A., & Ellis, C. (2015). Increasing role of medication therapy for managing student behavior. Beyond Behavior, 24, 31–37.CrossRefGoogle Scholar
  32. Section 504 of the Rehabilitation Act of 1973, 34. C.F.R. Part 104.Google Scholar
  33. Shahidullah, J. D., & Carlson, J. S. (2014). Survey of nationally certified school psychologists’ roles and training in psychopharmacology. Psychology in the Schools, 51, 705–721.  https://doi.org/10.1002/pits.21776.CrossRefGoogle Scholar
  34. Spetie, L., & Arnold, L. E. (2007). Ethical issues in child psychopharmacology research and practice: Emphasis on preschoolers. Psychopharmacology (Berl), 191, 15–26.CrossRefGoogle Scholar
  35. Steinhausen, H. (2015). Recent international trends in psychotropic medication prescriptions for children and adolescents. European Child and Adolescent Psychiatry, 24, 635–640.CrossRefGoogle Scholar
  36. United States Department of Education, Office for Civil Rights. (2016, July 26). Dear colleague letter and resource guide on students with ADHD. Retrieved from https://www2.ed.gov/about/offices/list/ocr/letters/colleague-201607-504-adhd.pdf.
  37. United States Department of Health and Human Services. (2014). Guidance regarding methods for de-identification of protected health information in accordance with the health insurance portability and accountability act (hipaa) privacy rule. Washington, DC: US Department of Health and Human Services.Google Scholar
  38. United States Department of Health and Human Services. (2015). US Department of Education. Joint Guidance on the Application of the Family Educational Rights and Privacy Act (FERPA) and the Health Insurance Portability and Accountability Act of 1996 (HIPAA) to Student Health Records. Washington, DC: US Department of Health and Human Services.Google Scholar
  39. Visser, S. N., Danielson, M. L., Bitsko, R. H., Holbrook, J. R., Kogan, M. D., Ghandour, R. M., … Blumberg, S. J. (2014). Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003–2011. Journal of the American Academy of Child & Adolescent Psychiatry, 53, 34–46.CrossRefGoogle Scholar
  40. Volpe, R. J., Heick, P. F., & Gureasko-Moore, D. (2005). An agile behavioral model for monitoring the effects of stimulant medication in school settings. Psychology in the Schools, 42, 509–523.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Lehigh UniversityBethlehemUSA

Personalised recommendations